Melanoma in infants, caused by a gene fusion involving the anaplastic lymphoma kinase (ALK). Read more about Melanoma in infants, caused by a gene fusion involving the anaplastic lymphoma kinase (ALK).
Multiple desmoplastic Spitz nevi with BRAF fusions in a patient with ring chromosome 7 syndrome. Read more about Multiple desmoplastic Spitz nevi with BRAF fusions in a patient with ring chromosome 7 syndrome.
The role of technology in melanoma screening and diagnosis. Read more about The role of technology in melanoma screening and diagnosis.
GNAQQ209L expression initiated in multipotent neural crest cells drives aggressive melanoma of the central nervous system. Read more about GNAQQ209L expression initiated in multipotent neural crest cells drives aggressive melanoma of the central nervous system.
A dual pathway inhibition strategy using BKM120 combined with vemurafenib is poorly tolerated in BRAF V600E/K mutant advanced melanoma. Read more about A dual pathway inhibition strategy using BKM120 combined with vemurafenib is poorly tolerated in BRAF V600E/K mutant advanced melanoma.
The tumor suppressor BAP1 cooperates with BRAFV600E to promote tumor formation in cutaneous melanoma. Read more about The tumor suppressor BAP1 cooperates with BRAFV600E to promote tumor formation in cutaneous melanoma.
Dual MEK/AKT inhibition with trametinib and GSK2141795 does not yield clinical benefit in metastatic NRAS-mutant and wild-type melanoma. Read more about Dual MEK/AKT inhibition with trametinib and GSK2141795 does not yield clinical benefit in metastatic NRAS-mutant and wild-type melanoma.
Filling the gaps in the genomic catalogue of melanoma subtypes. Read more about Filling the gaps in the genomic catalogue of melanoma subtypes.
The state of melanoma: challenges and opportunities. Read more about The state of melanoma: challenges and opportunities.
Clinical activity of the MEK inhibitor trametinib in metastatic melanoma containing BRAF kinase fusion. Read more about Clinical activity of the MEK inhibitor trametinib in metastatic melanoma containing BRAF kinase fusion.
